Advanz Pharma’s liver disease drug pulled from European market after court hearing – Pharmaceutical Technology
Advanz said it is considering next steps, including options to enable continued access for patients. Credit: Yavdat via Shutterstock. Advanz Pharma’s liver disease drug Ocaliva